Pre-transplant assessment of pp65-specific CD4 T cell responses identifies CMV-seropositive patients treated with rATG at risk of late onset infection

Copyright © 2020 Elsevier Inc. All rights reserved.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 211(2020) vom: 15. Feb., Seite 108329
Auteur principal: López-Oliva, Maria O (Auteur)
Autres auteurs: Martínez, Virginia, Rodríguez-Sanz, Aranzazu, Álvarez, Laura, Santana, M José, Selgas, Rafael, Jiménez, Carlos, Bellón, Teresa
Format: Article en ligne
Langue:English
Publié: 2020
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Clinical Trial Journal Article Research Support, Non-U.S. Gov't Adaptive immune response Cytokine flow cytometry Cytomegalovirus Immune monitoring Kidney transplant Antilymphocyte Serum Antiviral Agents plus... Immunosuppressive Agents thymoglobulin D7RD81HE4W Valganciclovir GCU97FKN3R